STOCK TITAN

Clover Health Investments, Corp - CLOV STOCK NEWS

Welcome to our dedicated page for Clover Health Investments news (Ticker: CLOV), a resource for investors and traders seeking the latest updates and insights on Clover Health Investments stock.

Clover Health Investments, Corp. (NASDAQ: CLOV) is a physician enablement company dedicated to bringing high-quality, affordable healthcare to seniors, particularly those who have historically faced barriers to access. By leveraging its proprietary platform, Clover Assistant, Clover Health empowers physicians to make data-driven, personalized decisions, enhancing patient outcomes while reducing unnecessary costs.

Operating primarily through its Insurance and Non-Insurance segments, Clover Health offers a variety of Medicare Advantage plans, including PPO and HMO options. Through the Insurance segment, Clover Health delivers comprehensive healthcare coverage to members across multiple states. Its Non-Insurance segment participates in the ACO REACH Model, reinforcing its commitment to value-based care.

Clover Assistant aggregates patient data from across the healthcare ecosystem and provides real-time, personalized recommendations at the point of care. This tool has proven effective in improving medication adherence and managing chronic conditions, such as diabetes, high blood pressure, and high cholesterol, ultimately enhancing clinical outcomes.

Recent achievements highlight Clover Health's strategic focus and operational success. The company has demonstrated significant progress in improving medication adherence through the use of Clover Assistant. Additionally, Clover Health is targeting Adjusted EBITDA profitability for the full year of 2024, driven by strong performance in their Medicare plans and strategic investments in technology and care management.

Partnership efforts, such as those with Quartet Health, aim to enhance care delivery for underserved and high-risk patient populations through Clover's home-based care model. This initiative is part of Clover Health's broader strategy to improve health equity and provide comprehensive, coordinated care.

With a steadfast commitment to making care accessible and ensuring patients have the freedom to choose their doctors, Clover Health continues to drive innovation in healthcare. For more information about Clover Assistant, visit Clover Assistant.

Stay updated on the latest developments and strategic moves by Clover Health by following their news updates:

  • Higher fill rates result in improved performance on medication adherence quality measures in the Medicare Advantage Stars program for members where Clover Assistant was used (January 8, 2024)
  • Clover Health targeting Adjusted EBITDA profitability for the full-year 2024 (January 10, 2024)
  • Clay Thornton appointed Chief Financial Officer of Medicare Advantage division (March 7, 2024)
  • Partnership with Quartet Health to enhance home-based care delivery (February 5, 2024)
  • Counterpart Assistant now available for external payors and providers (May 29, 2024)
Rhea-AI Summary

Clover Health (Nasdaq: CLOV) has announced that CFO Joseph Wagner will leave the company on August 13 for personal reasons. Mark Herbers from AlixPartners, LLP will serve as Interim CFO until a permanent replacement is found. Lee Shapiro, Clover's Audit Committee Chair, will lead the search for a new CFO. Wagner expressed gratitude for his time at Clover, highlighting the challenges and achievements during the COVID-19 pandemic and the company's transition to public status. Clover continues its mission to improve healthcare access, particularly for seniors, while emphasizing health equity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.84%
Tags
none
-
Rhea-AI Summary

Clover Health (Nasdaq: CLOV) announced the hiring of Prabhdeep Singh as Chief Growth Officer and Justin Joseph as Chief Strategy & Development Officer. Singh, formerly of WeWork and Uber, will focus on member growth and service area expansion. Joseph, with experience from Palantir and Deloitte, aims to drive strategic partnerships. This leadership expansion aligns with Clover's mission to improve health equity for seniors. Clover plans to expand coverage to 101 new counties, pending CMS approval, with enrollment starting in the upcoming Annual Election Period.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
none
-
Rhea-AI Summary

Clover Health (NASDAQ: CLOV) plans to nearly double its geographic footprint, expanding its Medicare Advantage plans to 209 counties across nine states, pending CMS approval. This includes 101 new counties, enhancing access for underserved seniors. Current services are offered in 108 counties with approximately 66,300 members. The expansion will allow eligible individuals to enroll during the Annual Election Period from October 15 to December 7 for coverage starting January 1, 2022. Clover also aims to introduce new benefits, including expanded over-the-counter and grocery benefits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.29%
Tags
none
Rhea-AI Summary

Clover Health (Nasdaq: CLOV) announced the hiring of South Fulton City Councilwoman Carmalitha Gumbs as Head of Community Engagement and Partnerships. Gumbs will lead initiatives to enhance Clover's presence and assist Medicare beneficiaries in Metro Atlanta and the Southeast. CEO Vivek Garipalli praised her extensive experience and commitment to health equity. Clover Health focuses on providing affordable healthcare to underserved seniors, leveraging technology like the Clover Assistant to improve medical outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.95%
Tags
partnership
-
Rhea-AI Summary

Upward Health has partnered with Clover Health to provide integrated in-home medical and behavioral care for patients facing complex challenges. This collaboration, part of CMS' new Direct Contracting initiative, will enhance Clover's Clover Home Care program across New York, Pennsylvania, Georgia, and Texas. The partnership aims to optimize health outcomes while managing costs efficiently. Upward Health's services include Facilitated Virtual Care™ to ensure timely access to necessary care for high-risk patients, emphasizing a holistic approach to healthcare delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.25%
Tags
none
-
Rhea-AI Summary

Clover Health (Nasdaq: CLOV) announced plans to expand its in-home primary care program, Clover Home Care, through the new Direct Contracting model by CMS, focusing on improving health equity for underserved seniors. The program has successfully reduced hospitalizations by 17% and medical expenses by $325 per member monthly. Clover's home care services include direct access to physicians, maintaining existing primary care relationships, and leveraging technology to enhance patient care. New partnerships with Spiras Health and Upward Health are aimed at delivering exceptional care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.61%
Tags
none
Rhea-AI Summary

Clover Health (Nasdaq: CLOV) reported a record $200.3 million in revenue for Q1 2021, up 21% from $165.5 million in Q1 2020, driven by increased Medicare Advantage membership, which rose 18% to approximately 66,300. Lives under management nearly doubled to over 130,000 following the launch of Direct Contracting. However, GAAP Medical Care Ratio increased to 107.6%, reflecting higher COVID-19 related costs. The company anticipates total revenues between $810-$830 million for FY 2021, including an estimated $20-$30 million from Direct Contracting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.7%
Tags
-
Rhea-AI Summary

Clover Health (CLOV) has partnered with Roundtrip to enhance non-emergency medical transportation for its Medicare Advantage members. This initiative addresses transportation barriers faced by seniors, allowing users to book rides through Roundtrip's app, with options like rideshare and wheelchair vans. According to data, 5.8 million Americans have delayed medical care due to transportation issues. The collaboration aims to improve health outcomes by facilitating reliable transportation, integrating Roundtrip's services with Clover's clinical tools.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.18%
Tags
none
-
Rhea-AI Summary

Clover Health (CLOV) announced it will report its Q1 2021 financial results on May 17, 2021, prior to market open. A conference call will be held at 8:30 a.m. ET to discuss the results. The company's mission is to enhance health outcomes for seniors using a technology platform that analyzes health data, aiming to improve medical outcomes and reduce costs. Clover has offices in multiple locations, including Nashville and San Francisco.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.64%
Tags
conferences earnings
Rhea-AI Summary

Clover Health Investments, Corp. (Nasdaq: CLOV) announced the appointment of Demetrios L. Kouzakas to its Board of Directors, where he will also serve on the Audit Committee. Kouzakas brings extensive experience from his previous roles in the Medicare division at UnitedHealth and as Director of the Center for Medicare at CMS. CEO Vivek Garipalli highlighted Kouzakas's expertise in Medicare regulations and strategic business acumen as vital for Clover's mission to improve health outcomes for seniors. Kouzakas expressed excitement about Clover's technology fostering better care coordination.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
none

FAQ

What is the current stock price of Clover Health Investments (CLOV)?

The current stock price of Clover Health Investments (CLOV) is $4.18 as of October 17, 2024.

What is the market cap of Clover Health Investments (CLOV)?

The market cap of Clover Health Investments (CLOV) is approximately 2.2B.

What does Clover Health do?

Clover Health is a physician enablement company that focuses on providing affordable, high-quality healthcare for seniors, particularly those on Medicare.

What is Clover Assistant?

Clover Assistant is Clover Health's proprietary software platform designed to aggregate patient data and provide real-time, personalized recommendations to physicians.

How does Clover Health generate revenue?

Clover Health primarily generates revenue through its Insurance segment by offering Medicare Advantage plans. A smaller portion comes from the Non-Insurance segment, which participates in the ACO REACH Model.

What recent achievements has Clover Health made?

Recent achievements include improving medication adherence rates through Clover Assistant and targeting Adjusted EBITDA profitability for the full year of 2024.

What types of Medicare Advantage plans does Clover Health offer?

Clover Health offers both PPO and HMO Medicare Advantage plans.

What is the significance of Clover Health's partnership with Quartet Health?

The partnership aims to enhance care for underserved and high-risk populations through Clover's home-based care model, improving both physical and behavioral health outcomes.

How does Clover Assistant benefit physicians?

Clover Assistant provides real-time, data-driven insights to physicians, aiding in early detection and management of chronic diseases, ultimately improving patient care.

What is the focus of Clover Health's Non-Insurance segment?

The Non-Insurance segment focuses on value-based care models, including participation in the ACO REACH Model.

What are Clover Health's future goals?

Clover Health aims to achieve Adjusted EBITDA profitability for the full year of 2024 and expand the reach of Clover Assistant through its Counterpart Assistant initiative.

How does Clover Health improve healthcare accessibility?

Clover Health is committed to making healthcare accessible by offering affordable Medicare Advantage plans and ensuring patients can choose their preferred doctors.

Clover Health Investments, Corp

Nasdaq:CLOV

CLOV Rankings

CLOV Stock Data

2.21B
407.82M
9.09%
18.55%
6.54%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States of America
FRANKLIN